DJ Bolt Biotherapeutics Upsized IPO Priced Above Increased Expectations >BOLT
By Colin Kellaher
Bolt Biotherapeutics Inc. said its upsized initial public offering of 11.5 million shares was priced at $20 apiece, above already increased expectations.
The Redwood City, Calif., clinical-stage immuno-oncology company previously raised the size and price range of the offering to 10.5 million shares at $18 to $19 each from earlier plans to sell about 8.83 million shares at between $16 and $18.
Bolt said it granted the underwriters a 30-day option to buy up to an additional 1.73 million shares.
Bolt shares are slated to begin trading Friday under the symbol BOLT.
Write to Colin Kellaher at firstname.lastname@example.org
(END) Dow Jones Newswires
February 05, 2021 05:58 ET (10:58 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.